Researchers demonstrated that newly developed molecules designed to block an immune checkpoint can trigger a powerful immune response against tumors. Scientists at MIT and Stanford University have ...

In most solid tumors, high numbers of regulatory T (Treg) cells are associated with poorer outcomes because they dampen the ...

A study by the Mildred Scheel Early Career Center group led by Dr. Mohamed Elgendy at the TUD Faculty of Medicine provides ...

Anal cancer is often linked to HPV, with squamous cell carcinoma being the most common type. Diagnosis involves exams, ...

Cancer has a talent for hiding in plain sight, cloaking itself in sugary molecules that convince the immune system to stand down. Researchers at MIT and Stanford have now engineered a way to rip away ...

It develops from the abnormal multiplication of T cells, or T-lymphocytes, a type of white blood cell essential for immune system function. The specific treatment course and prognosis for T-cell ...

Researchers are edging closer to something long imagined but never quite within reach: a single vaccine platform that could be adapted to fight many kinds of cancer. Early experiments in animals and ...

Seals give birth only when conditions are right. After mating, a female seal can delay implantation of the embryo in the ...

Saved from precursor B-cell acute lymphoblastic leukemia, the Nobel Prize winning CAR T-cell therapy gave Bryn Ailinger a ...

Ongoing investigation into whether bee venom could help treat a certain type of cancer has been making "important progress," the leading researcher has told Newsweek. Experts at the Epigenetics Lab at ...